VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
| Horizon | Bear case (−1σ) | Base case | Bull case (+1σ) |
|---|---|---|---|
| 1 Month | $0.13 (-27.3%) | $0.18 | $0.25 (+37.6%) |
| 3 Months | $0.10 (-42.4%) | $0.18 | $0.31 (+73.7%) |
| 6 Months | $0.08 (-54.2%) | $0.18 | $0.39 (+118.3%) |
| 12 Months | $0.06 (-66.8%) | $0.18 | $0.54 (+201.7%) |